Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luyao Kevin Xu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cell Chemical Biology|December 22, 2023
Knocking off cancer's HAT: CSS1477 disrupts oncogenic programsLuyao Kevin Xu, Panagiotis Ntziachristos
Methods in Enzymology|July 9, 2010
Thioredoxin and redox signaling in vasculature-studies using Trx2 endothelium-specific transgenic miceWang Min, Luyao Kevin Xu, Huanjiao Jenny Zhou, et al.
Cell Death & Disease|January 6, 2026
Dual Bcl-2/Bcl-xl inhibition via AZD0466 combines with immune checkpoint blockade to enhance anti-tumour activityDane M Newman, Courtney L Andersen, Leonie A Cluse, et al.
Leukemia|August 14, 2025
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemiaPatrícia Amaral, Rhona Christie, Daisy O F Gresham, et al.
Blood|May 28, 2025
HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemiaJonas De Kesel, Igor Fijalkowski, Tim Pieters, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cell Chemical Biology|December 22, 2023
Knocking off cancer's HAT: CSS1477 disrupts oncogenic programsLuyao Kevin Xu, Panagiotis Ntziachristos
Methods in Enzymology|July 9, 2010
Thioredoxin and redox signaling in vasculature-studies using Trx2 endothelium-specific transgenic miceWang Min, Luyao Kevin Xu, Huanjiao Jenny Zhou, et al.
Cell Death & Disease|January 6, 2026
Dual Bcl-2/Bcl-xl inhibition via AZD0466 combines with immune checkpoint blockade to enhance anti-tumour activityDane M Newman, Courtney L Andersen, Leonie A Cluse, et al.
Leukemia|August 14, 2025
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemiaPatrícia Amaral, Rhona Christie, Daisy O F Gresham, et al.
Blood|May 28, 2025
HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemiaJonas De Kesel, Igor Fijalkowski, Tim Pieters, et al.
Pageof 1